Petition Ensure the Pfizer and Flynn Pharma CMA fines are used solely to improve NHS care

Pharmaceutical companies Pfizer and Flynn Pharma have been fined a total of £89.4m by the Competition and Marketing Authority for exploiting a monopoly position over the marketing of the epilepsy drug Epanutin. Their actions have cost the NHS an estimated £44m per year for the last 4 years.

More details

The cost of this scandal has been entirely born by the NHS, and if all the fines are returned to the NHS it will still fall short of the £176m extra the NHS has had to pay for this vital drug. Patients with epilepsy have been most affected, and so some of the money should be used to employ Epilepsy Nurses to improve epilepsy care. See https://binscombedoctorblog.wordpress.com/2012/10/06/the-marketing-of-epanutin-re-energising-a-product-for-an-underserved-population-or-big-pharma-behaving-badly/

This petition closed early because of a General Election Find out more on the Petitions Committee website

1,336 signatures

Show on a map

10,000

Date closed 3 May 2017
Get petition data (json format)

About petition data

The data shows the number of people who have signed the petition by country as well as in the constituency of each Member of Parliament. This data is available for all petitions on the site. It is not a list of people who have signed the petition. The only name that is shared on the site is that of the petition creator.